Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
43 hedge funds and large institutions have $16.1M invested in Bio-Path Holdings Inc in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 4 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 48 → 43 (-5)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
40% less capital invested
Capital invested by funds: $26.7M → $16.1M (-$10.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.5M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$116K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$94.4K |
| 4 |
State Street
Boston,
Massachusetts
|
+$43.6K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$36.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$229K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$155K |
| 3 |
Morgan Stanley
New York
|
-$127K |
| 4 |
Citigroup
New York
|
-$79.9K |
| 5 |
JP Morgan Chase
New York
|
-$54.5K |
BPTH Hedge Fund Activity: Q1 2017 in Review
43 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2017, worth a combined $16.1M — down 40% from $26.7M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BPTH and 3 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 12 added.
The largest buyer was BlackRock, adding an estimated $3.5M. The largest seller was Millennium Management, cutting an estimated $229K.
- 43 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2017, down from 48 in Q4 2016.
- Funds reported $16.1M of Bio-Path Holdings Inc stock for Q1 2017, down 40% quarter-over-quarter.
- 3 funds opened new Bio-Path Holdings Inc positions in Q1 2017 and 4 closed out, a net change of -1 holder.
- The largest Bio-Path Holdings Inc buyer in Q1 2017 was BlackRock, an estimated $3.5M added.
- The largest Bio-Path Holdings Inc seller in Q1 2017 was Millennium Management, an estimated $229K sold.
Based on aggregated 13F filings for Q1 2017.